112 related articles for article (PubMed ID: 7477641)
1. Deoxyspergualin: a new immunosuppressive drug for the treatment of auto-immune disease.
Nikolic-Paterson DJ; Kerr PG; Lan HY; Tesch GH; Atkins RC
Nephron; 1995; 70(4):391-6. PubMed ID: 7477641
[No Abstract] [Full Text] [Related]
2. Deoxyspergualin--a different and intriguing immunosuppressant.
Tufveson G; Gannedahl G
Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954
[No Abstract] [Full Text] [Related]
3. 15-deoxyspergualin: from cytostasis to immunosuppression.
Dickneite G; Schorlemmer HU; Weinmann E; Sedlacek HH
Behring Inst Mitt; 1988 Apr; (82):231-9. PubMed ID: 3044340
[TBL] [Abstract][Full Text] [Related]
4. Gusperimus: immunological mechanism and clinical applications.
Perenyei M; Jayne DR; Floßmann O
Rheumatology (Oxford); 2014 Oct; 53(10):1732-41. PubMed ID: 24501242
[TBL] [Abstract][Full Text] [Related]
5. Deoxyspergualin: mechanism of action and pharmacokinetics.
Ramos EL; Nadler SG; Grasela DM; Kelley SL
Transplant Proc; 1996 Apr; 28(2):873-5. PubMed ID: 8623442
[No Abstract] [Full Text] [Related]
6. FK506 and deoxyspergualin: experimental studies and clinical applications.
Suzuki S
Transpl Immunol; 1994 Sep; 2(3):190-8. PubMed ID: 7528087
[No Abstract] [Full Text] [Related]
7. Immunosuppressive drugs.
Collier SJ
Curr Opin Immunol; 1989-1990; 2(6):854-8. PubMed ID: 2484794
[No Abstract] [Full Text] [Related]
8. Immunosuppressive mechanisms and action of deoxyspergualin in experimental and clinical studies. Japanese Collaborative Transplant Study Group of NKT-01.
Amemiya H
Transplant Proc; 1995 Feb; 27(1):31-2. PubMed ID: 7879015
[No Abstract] [Full Text] [Related]
9. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
[TBL] [Abstract][Full Text] [Related]
10. A new immunosuppressive agent, 15-deoxyspergualin, in dog renal allografting.
Amemiya H; Suzuki S; Niiya S; Fukao K; Yamanaka N; Ito J
Transplant Proc; 1989 Jun; 21(3):3468-70. PubMed ID: 2662490
[No Abstract] [Full Text] [Related]
11. Stability and immunosuppressive activity of deoxyspergualin in comparison with deoxymethylspergualin.
Fujii H; Takada T; Nemoto K; Abe F; Takeuchi T
Transplant Proc; 1989 Jun; 21(3):3471-3. PubMed ID: 2525828
[No Abstract] [Full Text] [Related]
12. Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 1. Structural modifications of the hydroxyglycine moiety.
Lebreton L; Annat J; Derrepas P; Dutartre P; Renaut P
J Med Chem; 1999 Jan; 42(2):277-90. PubMed ID: 9925733
[TBL] [Abstract][Full Text] [Related]
13. Deoxyspergualin. Mechanism of action studies of a novel immunosuppressive drug.
Tepper MA
Ann N Y Acad Sci; 1993 Nov; 696():123-32. PubMed ID: 8109823
[No Abstract] [Full Text] [Related]
14. Preclinical studies with 15-deoxyspergualin in various animal models for autoimmune diseases.
Schorlemmer HU; Dickneite G
Ann N Y Acad Sci; 1993 Jun; 685():155-74. PubMed ID: 8363220
[No Abstract] [Full Text] [Related]
15. Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis.
Schorlemmer HU; Bartlett RR; Schleyerbach R; Seiler FR
Drugs Exp Clin Res; 1991; 17(10-11):471-84. PubMed ID: 1841036
[TBL] [Abstract][Full Text] [Related]
16. Deoxyspergualin: clinical experience.
Gores PF
Transplant Proc; 1996 Apr; 28(2):871-2. PubMed ID: 8623441
[No Abstract] [Full Text] [Related]
17. 15-Deoxyspergualin as an immunosuppressive agent in dogs.
Amemiya H; Suzuki S; Manabe H; Fukao K; Iwasaki Y; Dohi K; Isono K; Orita K; Yamanaka N
Transplant Proc; 1988 Feb; 20(1 Suppl 1):229-32. PubMed ID: 3279613
[No Abstract] [Full Text] [Related]
18. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.
Yuh DD; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605
[No Abstract] [Full Text] [Related]
19. Use of a novel immunosuppressive agent, deoxyspergualin, in a case of ABO-incompatible kidney transplantation.
Takahasi K; Ota K; Ooba S; Tanabe K; Fuchinoue S; Honda H; Teraoka S; Toma H; Agishi T; Amemiya H
Clin Transpl; 1989; ():306-7. PubMed ID: 2487584
[No Abstract] [Full Text] [Related]
20. [15+/-deoxyspergualin, hope for patients with multiple sclerosis?].
Kappos L; Theobald K; Hartung HP
Nervenarzt; 1992 Dec; 63(12):768-71; discussion 772. PubMed ID: 1494394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
